Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion type Assertion NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_head.
- NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion description "[The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_provenance.
- NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion evidence source_evidence_literature NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_provenance.
- NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion SIO_000772 23177026 NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_provenance.
- NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion wasDerivedFrom befree-2016 NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_provenance.
- NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_assertion wasGeneratedBy ECO_0000203 NP1030692.RAAllymn8qYSdmL3FdTj07nrItP3DoaK_SpHj_u1fi0Io130_provenance.